The Emerging Markets Opportunity
The Emerging Markets Opportunity
Society of Pension Professionals Society of Pension Professionals 6th November 2014 Julian Mayo Co-Chief Investment Officer Charlemagne Capital (UK) Limited
1
The Emerging Markets Opportunity Society of Pension Professionals - - PowerPoint PPT Presentation
The Emerging Markets Opportunity The Emerging Markets Opportunity Society of Pension Professionals Society of Pension Professionals 6 th November 2014 Julian Mayo Co-Chief Investment Officer Charlemagne Capital (UK) Limited 1 The Emerging
The Emerging Markets Opportunity
Society of Pension Professionals Society of Pension Professionals 6th November 2014 Julian Mayo Co-Chief Investment Officer Charlemagne Capital (UK) Limited
1
The Emerging Markets Opportunity
2
The Emerging Markets Opportunity
3
The Emerging Markets Opportunity
30 40 50
Citi's Structural Reforms Index
Better 10 20 30 ‐20 ‐10 Worse ‐40 ‐30 Mexico India China Malaysia lippines Taiwan donesia Korea
Turkey Nigeria Poland Brazil Panama Peru Thailand Egypt Chile h Africa Russia rgentina Hungary M Phi Ind Co P T Sout Ar H
4
Source: Haver, Citi Research
The Emerging Markets Opportunity
8 10
Gross domestic product, constant prices
4 6 % 2 ‐4 ‐2 2007 2008 2009 2010 2011 2012 2013 2014 2015E Advanced economies Emerging market and developing economies
Source: IMF Research
5
The Emerging Markets Opportunity
60 80
Citi Economic Surprise Index
20 40 ‐40 ‐20 ‐80 ‐60 Jan 2010 Jul 2010 Jan 2011 Jul 2011 Jan 2012 Jul 2012 Jan 2013 Jul 2013 Jan 2014 Jul 2014 G10 EM
6
Source: Bloomberg, Citi Research
The Emerging Markets Opportunity
0%
Current Acct. % GDP, Current vs 2013Q2
‐4% ‐2% ‐8% ‐6% ‐12% ‐10% India Indonesia Brazil South Africa Turkey 2013Q2 2014Q2
7
Source: Haver, Citi Research
The Emerging Markets Opportunity
300% 350% Total Debt as % of GDP (Non Financial Private Sector + Govt ) 242% 246% 258% 274% 276% 278% 282% 284% 250% 300% 113% 116% 119% 134% 142% 142% 150% 158% 150% 200% 50% 100% 2006 2007 2008 2009 2010 2011 2012 2013 DM EM
Source: BIS, IMF, Haver Analytics, Morgan Stanley Research. DM = US, EA, UK, JPN EM = CHN, IND, KOR, IDN, MAL, THL, BRA, MEX, RUS, POL, CZE, HUN, TUR, IST, SAF
8
The Emerging Markets Opportunity
35 40 PE (x) 25 30 35 15 20 16x 13x 5 10 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 Global Emerging Markets
9
Source: MSCI, Citi Research
The Emerging Markets Opportunity
1.1 12M fwd PE of EM relative to DM 0.9 1.0
0.8 Average
0.6 0.7 Jan 2006 Jan 2007 Jan 2008 Jan 2009 Jan 2010 Jan 2011 Jan 2012 Jan 2013 Jan 2014
10
Source: MSCI, IBES, Thomson Reuters DataStream, HSBC
The Emerging Markets Opportunity
24% 25%
12M‐forward operating margins for EM and DM
20% 21% 22% 23% 17% 18% 19% 20% 15% 16% 2006 2007 2008 2009 2010 2011 2012 2013 2014 EM DM EM DM
11
Source: MSCI, IBES, Thomson Reuters DataStream, HSBC
The Emerging Markets Opportunity
10 15
Relative Earnings Revisions Ratio of Basket, 3mma %
5 15 ‐10 ‐5 ‐20 ‐15 2008 2009 2010 2011 2012 2013 2014 FY1 FY2 FY1 FY2
12
Source: Charlemagne Capital
The Emerging Markets Opportunity
40 50
Earnings Revision Index EM vs DM
20 30 ‐10 10 ‐30 ‐20 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 3 per. Mov. Avg. (EM rel. DM)
13
Source: IBES Aggregate, Citi Research
The Emerging Markets Opportunity
1.1 200
GEMs Bond Spread vs Equity Spread
0.9 1.0 300 400 0.7 0.8 500 600 0.5 0.6 700 800 Jan 2009 Jul 2009 Jan 2010 Jul 2010 Jan 2011 Jul 2011 Jan 2012 Jul 2012 Jan 2013 Jul 2013 Jan 2014 EMBI Global Comp Spread, inverted (LHS) MSCI EM/US Price (RHS)
14
Source: Haver, MSCI, Datastream, Citi Research
The Emerging Markets Opportunity
15
The Emerging Markets Opportunity
16
The Emerging Markets Opportunity
1.4 1.6
Import Coverage Ratio
FX reserves to Import 0 8 1.0 1.2 0.4 0.6 0.8 0.0 0.2 1989 1992 1995 1998 2001 2004 2007 2010 2013 AxJ LatAm EMEA
17
Source: CEIC, Haver, IMF, FactSet, Citi Research
The Emerging Markets Opportunity
110 120
EM vs DM public debt to GDP
Public Debt as % of GDP 70 80 90 100 40 50 60 70 20 30 40 1983 1988 1993 1998 2003 2008 DM EM
18
Source: CEIC, Haver, IMF, Citi Research
The Emerging Markets Opportunity
68% 70%
% of Working Population (aged 15‐64)
64% 66% 60% 62% 56% 58% 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 2016 2018 2020 2022 2024 DM EM
19
Source: Haver, United Nations, Citi Research
The Emerging Markets Opportunity
Korea 1 200 1,400 kg)
Steel Consumption Per Capita
Taiwan 800 1,000 1,200 tion Per Capita (k China Japan US 2013E 2014E 400 600 Steel Consumpt India 200 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 50,000 GDP C it (PPP 2012 C t t D ll ) GDP per Capita (PPP, 2012 Constant Dollar)
Source: WorldSteel, Conference Board, IMF, Morgan Stanley Research
20
The Emerging Markets Opportunity
110 120
Regional EPS since their 2007/08 peaks
90 100 60 70 80 40 50 ‐12 12 24 36 48 60 72 Peak time = 0 GEMS 7/2008 AC World 2/2008
Source: MSCI, Citi Research
21
The Emerging Markets Opportunity
35 40
EMs PE relative to Global
PE(x) 25 30 35 15 20 5 10 1994 1998 2002 2006 2010 2014 AC World GEMS
22
Source: Haver, MSCI, Citi Research
The Emerging Markets Opportunity
2% 4% 20% 40% ‐2% 0% ‐20% 0% 6% ‐4% 60% ‐40% ‐8% ‐6% ‐80% ‐60% 1988 1991 1994 1997 2000 2003 2006 2009 2012 EM PBV Discount to World (LHS) EM ROE rel. to World (RHS)
23
Source: EPFR Global, MSCI, Citi Research
The Emerging Markets Opportunity
14% 16% ROIC
Cross Section comparison of ROIC vs Capex to Payout ratio
EMEA IN ID RU TR US 10% 12% 14% EMAsia LATAM CN MY PH KR TW TH MX ZA PL US EU 6% 8% LATAM BR JP 2% 4% 0.8 2.8 4.8 6.8 8.8 10.8 12.8 0.8 2.8 4.8 6.8 8.8 10.8 12.8 Capex / Payout
24
Note: The payout here includes both dividend and shares buyback Source: Worldscope, FactSet, Citi Research
The Emerging Markets Opportunity
This document has been issued by Charlemagne Capital (UK) Limited for information purposes only and is not to be construed as a solicitation or an offer to purchase or sell any security or other financial instrument. Although the material in this report is based on information that Charlemagne Capital (UK) Limited considers reliable, Charlemagne Capital (UK) Limited does not make any t t ti ( i li d) i l ti t th l t li bilit f th i f ti t i d h i A i i d h i fl t j d t t th d t warranty or representation (express or implied) in relation to the accuracy, completeness or reliability of the information contained herein. Any opinions expressed herein reflect a judgment at the date
any form of recommendation related to the personal circumstances of investors or otherwise, nor does it constitute any specific or general recommendation to buy, hold, or sell financial instruments and does not thus create any relationship between Charlemagne Capital (UK) Limited and any investor. The document may not include all the up-to-date information required to make investment
investment decisions. In addition to the financial aspects, this should include, in particular, the legal and tax aspects of the investments. It is strongly recommended that any potential investor should contact a financial adviser and, where required, a lawyer or tax adviser. Furthermore, it should also be considered that the future performance of financial instruments and their return cannot be inferred from their past performance. The value of investments may go down as well as up and investors in financial instruments should be capable of bearing a total loss of investment. Neither Charlemagne Capital (UK) Limited nor any third party content provider shall be liable for any errors, inaccuracy, delay or updating of the published content of the provided document. Charlemagne Capital (UK) Limited expressly disclaims all warranties as to the accuracy of the content provided, or as to the use of the information for any purpose, as far as legally possible. This material is for the use of intended recipients only and neither the whole nor any part of this material may be duplicated in any form or by any means. Neither should any of this material be redistributed or disclosed to anyone without the prior consent of Charlemagne Capital (UK) Limited. Issuedby Charlemagne Capital (UK) Limited – a company authorised and regulated by the Financial Conduct Authority. Charlemagne Capital (UK) Limited 39 St James‘s Street London SW1A 1JD United Kingdom Tel: + 44 (0)20 7518 2100 Fax: + 44 (0)20 7518 2199 Website: www.charlemagnecapital.com Email: marketing@charlemagnecapital.com NB: Charlemagne Capital is the source of all information unless stated otherwise. 25